• Pfizer selects two targets under partnership with Wave biospectrumasia
    May 09, 2018
    Pfizer has nominated the fourth and fifth targets of the collaboration, designed to apply Wave’s stereochemistry platform across antisense and single-stranded RNA interference (RNAi) modalities
PharmaSources Customer Service